Net profit of Syncom Formulations (India) rose 70.66% to Rs 11.11 crore in the quarter ended September 2024 as against Rs 6.51 crore during the previous quarter ended September 2023. Sales rose 60.26% to Rs 102.31 crore in the quarter ended September 2024 as against Rs 63.84 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 102.31 | 63.84 | 60 |
| OPM % | 11.89 | 10.03 | - |
| PBDT | 16.15 | 9.33 | 73 |
| PBT | 14.85 | 8.45 | 76 |
| NP | 11.11 | 6.51 | 71 |